Olema Pharmaceuticals, Inc.

OLMA· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$11.28-1.48%

2026-08-03

Financials

Valuation Metrics

Olema Pharmaceuticals, Inc.'s Market Cap is $985M. At end of 2025 it was $2.28B. Ranked #2504 of 3,112 in US market (top 80%), #1032 of 1,445 on NASDAQ (top 71%), #192 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 71%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$985M	US#2,504/3,112 Sec#192/269
Revenue	$0.00	US#2,974/3,112 Sec#204/269
Net Income	$-185M	US—/3,112 Sec—/269
Total Assets	$531M	US#2,720/3,112 Sec#148/269
Net Assets	$480M	US#2,280/3,112 Sec#117/269
Value
P/B	2.05x	US#1,219/3,112 Sec#54/269
FCF Yield	-15.09%	US—/3,112 Sec—/269
Profitability
ROE	-38.53%	US#2,684/3,112 Sec#150/269
ROA	-34.89%	US#2,902/3,112 Sec#175/269
Financial Health
Debt Ratio	10.44%	US#118/3,112 Sec#51/269
Total Debt	$956000.00	US#2,932/3,112 Sec#245/269
FCF	$-149M	US#2,681/3,112 Sec#191/269
Cash	$53M	US#2,563/3,112 Sec#225/269
Current Ratio	10.88x	US#229/3,112 Sec#71/269
Performance
1Y Return	111.63%	US#266/3,112 Sec#73/269
1M Return	-10.76%	US#2,635/3,112 Sec#171/269
From 52W High	-68.89%	US#3,007/3,112 Sec#252/269
1Y MDD	-74.35%	US#2,987/3,112 Sec#251/269
Trading
Volume	732,584 shares	US#1,769/3,112 Sec#173/269
Trading Value	$8M	US#2,439/3,112 Sec#192/269
Per Share
EPS	$-1.78	US—/3,112 Sec—/269
BPS	$5.24	US#2,206/3,112 Sec#129/269